Compounds > c.i. 42510
Page last updated: 2024-08-21

c.i. 42510 and Multiple Primary Neoplasms

c.i. 42510 has been researched along with Multiple Primary Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barneveld, PC; Bavelaar-Croon, CD; Bosscha, K; Contant, CM; de Roos, WK; van la Parra, RF1
Johnson, DP; Symonds, DA; Wheeless, CR1

Other Studies

2 other study(ies) available for c.i. 42510 and Multiple Primary Neoplasms

ArticleYear
A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:10

    Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; Humans; Lymph Node Excision; Lymph Nodes; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2014
Feulgen cytometry in simultaneous endometrial and ovarian carcinoma.
    Cancer, 1988, Jun-15, Volume: 61, Issue:12

    Topics: Adult; Carcinoma; Coloring Agents; Diagnosis, Differential; DNA, Neoplasm; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Ovarian Neoplasms; Ploidies; Rosaniline Dyes; Uterine Neoplasms

1988